Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus

K. O. Cho, G. S. Rhee, S. J. Kwack, S. Y. Chung, S. Y. Kim

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a powerful releaser of 5-HT and chronic use of this drug can cause depletion of monoamines. Recently, concerns about the risk of adult brain damage due to fetal exposure to MDMA have been raised. We investigated whether developmental MDMA exposure affected adult neurogenesis in C57 black/6 mice. MDMA (1.25 or 20 mg/kg, p.o.) or vehicle was administered daily to the mother from prenatal 6th day to postnatal 21st day. When the offspring were 11 weeks old, they were injected with 5-bromo-2′-deoxyuridine (BrdU) (120 mg/kg, i.p.) once a day for 4 days. After 24 h or 28 days, the animals were killed to count the BrdU-positive cells in the dentate gyrus. At 24 h after the last BrdU injection, the number of BrdU-positive cells in the offspring developmentally exposed to MDMA was significantly lower than that of the control group. At 28 days post-BrdU labeling, BrdU-positive cells in the dentate gyrus of female offspring with developmental exposure to high dose MDMA were significantly fewer compared with the control group. In addition, most BrdU-positive cells were co-labeled with the mature neuronal marker, neuronal nuclei, while a few BrdU-labeled cells were merged with an astrocyte marker. Our results suggest that developmental exposure to MDMA can result in decreases in the proliferation and survival of mature newborn cells in the adult dentate gyrus.

Original languageEnglish (US)
Pages (from-to)1034-1041
Number of pages8
JournalNeuroscience
Volume154
Issue number3
DOIs
StatePublished - Jun 26 2008

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Neurogenesis
Deoxyuridine
Hippocampus
Down-Regulation
Dentate Gyrus
Control Groups
Bromodeoxyuridine
Astrocytes
Serotonin
Injections
Brain

Keywords

  • abuse
  • adult neurogenesis
  • BrdU
  • dentate gyrus
  • ecstasy
  • hippocampus

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus. / Cho, K. O.; Rhee, G. S.; Kwack, S. J.; Chung, S. Y.; Kim, S. Y.

In: Neuroscience, Vol. 154, No. 3, 26.06.2008, p. 1034-1041.

Research output: Contribution to journalArticle

Cho, K. O. ; Rhee, G. S. ; Kwack, S. J. ; Chung, S. Y. ; Kim, S. Y. / Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus. In: Neuroscience. 2008 ; Vol. 154, No. 3. pp. 1034-1041.
@article{d1c24ec1ef354e7aa80cdc64615eeb56,
title = "Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus",
abstract = "3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a powerful releaser of 5-HT and chronic use of this drug can cause depletion of monoamines. Recently, concerns about the risk of adult brain damage due to fetal exposure to MDMA have been raised. We investigated whether developmental MDMA exposure affected adult neurogenesis in C57 black/6 mice. MDMA (1.25 or 20 mg/kg, p.o.) or vehicle was administered daily to the mother from prenatal 6th day to postnatal 21st day. When the offspring were 11 weeks old, they were injected with 5-bromo-2′-deoxyuridine (BrdU) (120 mg/kg, i.p.) once a day for 4 days. After 24 h or 28 days, the animals were killed to count the BrdU-positive cells in the dentate gyrus. At 24 h after the last BrdU injection, the number of BrdU-positive cells in the offspring developmentally exposed to MDMA was significantly lower than that of the control group. At 28 days post-BrdU labeling, BrdU-positive cells in the dentate gyrus of female offspring with developmental exposure to high dose MDMA were significantly fewer compared with the control group. In addition, most BrdU-positive cells were co-labeled with the mature neuronal marker, neuronal nuclei, while a few BrdU-labeled cells were merged with an astrocyte marker. Our results suggest that developmental exposure to MDMA can result in decreases in the proliferation and survival of mature newborn cells in the adult dentate gyrus.",
keywords = "abuse, adult neurogenesis, BrdU, dentate gyrus, ecstasy, hippocampus",
author = "Cho, {K. O.} and Rhee, {G. S.} and Kwack, {S. J.} and Chung, {S. Y.} and Kim, {S. Y.}",
year = "2008",
month = "6",
day = "26",
doi = "10.1016/j.neuroscience.2008.04.040",
language = "English (US)",
volume = "154",
pages = "1034--1041",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus

AU - Cho, K. O.

AU - Rhee, G. S.

AU - Kwack, S. J.

AU - Chung, S. Y.

AU - Kim, S. Y.

PY - 2008/6/26

Y1 - 2008/6/26

N2 - 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a powerful releaser of 5-HT and chronic use of this drug can cause depletion of monoamines. Recently, concerns about the risk of adult brain damage due to fetal exposure to MDMA have been raised. We investigated whether developmental MDMA exposure affected adult neurogenesis in C57 black/6 mice. MDMA (1.25 or 20 mg/kg, p.o.) or vehicle was administered daily to the mother from prenatal 6th day to postnatal 21st day. When the offspring were 11 weeks old, they were injected with 5-bromo-2′-deoxyuridine (BrdU) (120 mg/kg, i.p.) once a day for 4 days. After 24 h or 28 days, the animals were killed to count the BrdU-positive cells in the dentate gyrus. At 24 h after the last BrdU injection, the number of BrdU-positive cells in the offspring developmentally exposed to MDMA was significantly lower than that of the control group. At 28 days post-BrdU labeling, BrdU-positive cells in the dentate gyrus of female offspring with developmental exposure to high dose MDMA were significantly fewer compared with the control group. In addition, most BrdU-positive cells were co-labeled with the mature neuronal marker, neuronal nuclei, while a few BrdU-labeled cells were merged with an astrocyte marker. Our results suggest that developmental exposure to MDMA can result in decreases in the proliferation and survival of mature newborn cells in the adult dentate gyrus.

AB - 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a powerful releaser of 5-HT and chronic use of this drug can cause depletion of monoamines. Recently, concerns about the risk of adult brain damage due to fetal exposure to MDMA have been raised. We investigated whether developmental MDMA exposure affected adult neurogenesis in C57 black/6 mice. MDMA (1.25 or 20 mg/kg, p.o.) or vehicle was administered daily to the mother from prenatal 6th day to postnatal 21st day. When the offspring were 11 weeks old, they were injected with 5-bromo-2′-deoxyuridine (BrdU) (120 mg/kg, i.p.) once a day for 4 days. After 24 h or 28 days, the animals were killed to count the BrdU-positive cells in the dentate gyrus. At 24 h after the last BrdU injection, the number of BrdU-positive cells in the offspring developmentally exposed to MDMA was significantly lower than that of the control group. At 28 days post-BrdU labeling, BrdU-positive cells in the dentate gyrus of female offspring with developmental exposure to high dose MDMA were significantly fewer compared with the control group. In addition, most BrdU-positive cells were co-labeled with the mature neuronal marker, neuronal nuclei, while a few BrdU-labeled cells were merged with an astrocyte marker. Our results suggest that developmental exposure to MDMA can result in decreases in the proliferation and survival of mature newborn cells in the adult dentate gyrus.

KW - abuse

KW - adult neurogenesis

KW - BrdU

KW - dentate gyrus

KW - ecstasy

KW - hippocampus

UR - http://www.scopus.com/inward/record.url?scp=45049085400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45049085400&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2008.04.040

DO - 10.1016/j.neuroscience.2008.04.040

M3 - Article

C2 - 18511203

AN - SCOPUS:45049085400

VL - 154

SP - 1034

EP - 1041

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 3

ER -